Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 8/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28452779 | 0.81 | CA2 (0.53) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL11720174 | 0.79 | CA2 (0.38) | ALDH1A1TDP1CA2MAPK1CA1 | |
| SCHEMBL4281881 | 0.73 | ALDH1A1 (0.62) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL18613982 | 0.73 | LMNA (0.39) | CA2CA1LMNA | |
| SCHEMBL4652969 | 0.71 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL4274177 | 0.71 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL4269643 | 0.71 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL16594856 | 0.71 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL4654331 | 0.71 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL11067651 | 0.71 | LMNA (0.43) | CA2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2136767-B1 | COSMETIC COMPOSITIONS CONTAINING ESTERS BASED ON 2-PROPYL HEPTANOL | COGNIS IP MAN GMBH (DE) | 2016-12-14 | — | — | EP | disclosed |
| US-8937100-B2 | Cosmetic composition containing calcium citrate and N-acylated aminoalcohol derivative | COGNIS IP MANAGEMENT GMBH (DE) | 2015-01-20 | — | — | US | disclosed |
| US-20140086863-A1 | Cosmetic Composition | COGNIS IP MANAGEMENT GMBH (DE) | 2014-03-27 | — | — | US | disclosed |
| US-8633244-B2 | Cosmetic compositions comprising esters based on 2-propylheptanol | COGNIS IP MANAGEMENT GMBH (DE) | 2014-01-21 | — | — | US | disclosed |
| US-8633333-B2 | Cosmetic compositions comprising esters based on 2-propylheptanol | COGNIS IP MANAGEMENT GMBH (DE) | 2014-01-21 | — | — | US | disclosed |
| US-8592484-B2 | Cosmetic composition containing calcium citrate and N-acylated aminoalcohol derivative to prevent dry skin and signs of cutaneous ageing | COGNIS IP MANAGEMENT GMBH (DE) | 2013-11-26 | — | — | US | disclosed |
| US-8580775-B2 | Use of derivatives of sinapinic acid and compositions comprising such derivatives | COGNIS IP MANAGEMENT GMBH (DE) | 2013-11-12 | — | — | US | disclosed |
| US-20130004555-A1 | Cosmetic Compositions Comprising Esters Based on 2-Propylheptanol | COGNIS IP MANAGEMENT GMBH (DE) | 2013-01-03 | — | — | US | disclosed |
| US-20130006010-A1 | Cosmetic Compositions Comprising Esters Based on 2-Propylheptanol | COGNIS IP MANAGEMENT GMBH (DE) | 2013-01-03 | — | — | US | disclosed |
| US-8288436-B2 | Cosmetic compositions comprising esters based on 2-propylheptanol | COGNIS IP MANAGEMENT GMBH (DE) | 2012-10-16 | — | — | US | disclosed |
| EP-2142164-A1 | COSMETIC COMPOSITIONS COMPRISING ESTERS BASED ON 2-PROPYLHEPTANOIC ACID | Cognis IP Management GmbH (DE) | 2010-01-13 | — | — | EP | disclosed |
| EP-2136767-A2 | COSMETIC COMPOSITIONS COMPRISING ESTERS BASED ON 2-PROPYLHEPTANOL | Cognis IP Management GmbH (DE) | 2009-12-30 | — | — | EP | disclosed |
| EP-2117498-A2 | USE OF DERIVATIVES OF 4-HYDROXYPHENOXY ACETIC ACID | Cognis IP Management GmbH (DE) | 2009-11-18 | — | — | EP | disclosed |
| WO-2008135187-A1 | COSMETIC COMPOSITIONS COMPRISING ESTERS BASED ON 2-PROPYLHEPTANOIC ACID | COGNIS IP MANAGEMENT GMBH (DE) | 2008-11-13 | — | — | WO | disclosed |
| EP-1990041-A1 | Cosmetic compositions containing esters based on 2-propylheptanoic acid | Cognis IP Management GmbH (DE) | 2008-11-12 | — | — | EP | disclosed |
| WO-2008131862-A2 | COSMETIC COMPOSITIONS COMPRISING ESTERS BASED ON 2-PROPYLHEPTANOL | COGNIS IP MANAGEMENT GMBH (DE) | 2008-11-06 | — | — | WO | disclosed |
| WO-2008107092-A2 | USE OF DERIVATIVES OF 4-HYDROXYPHENOXY ACETIC ACID | COGNIS IP MANAGEMENT GMBH (DE) | 2008-09-12 | — | — | WO | disclosed |
| EP-1967175-A1 | Use of derivatives of sinapinic acid and compositions comprising such derivatives | Cognis IP Management GmbH (DE) | 2008-09-10 | — | — | EP | disclosed |
| EP-1967176-A1 | Use of derivatives of 4-Hydroxyphenoxy acetic acid | Cognis IP Management GmbH (DE) | 2008-09-10 | — | — | EP | disclosed |
| EP-0083308-A1 | Process for stabilising fungicides | CIBA-GEIGY AG (CH) | 1983-07-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140086863-A1 | Cosmetic Composition | ASAH2, ASAH1, GLA | ALDH1A1 495/4885TDP1 1574/4885CYP3A4 4742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.